Novartis Ag NVS
NYSE NVS
$159.12 +2.88 (+1.84%)
As of: Aug 21, 2026 · 2:10 PM EDT

Novartis Ag (NVS) EPS (Basic) Growth (3y) (2012 - 2026)

Novartis Ag (NVS) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Johnson & Johnson 653.37 Bn 632.61 Bn 17.26 Bn 5.11%
2 AbbVie 469.65 Bn 463.08 Bn 12.70 Bn 21.23%
3 Merck 376.13 Bn 368.99 Bn 12.21 Bn 38.72%
4 Novartis Ag 303.28 Bn 295.59 Bn 11.24 Bn -59.02%
5 Astrazeneca 258.06 Bn 253.16 Bn 12.86 Bn 11.28%
6 Amgen 236.35 Bn 222.36 Bn 7.24 Bn 19.50%
7 Gilead Sciences 182.15 Bn 178.97 Bn 6.22 Bn -129.90%
8 Pfizer 159.57 Bn 147.87 Bn 10.94 Bn -28.08%
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -34.06%
10 Sanofi 55.20 Bn 47.82 Bn 10.79 Bn -35.71%

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.02%
Jun 30, 2025 -9.03%
Dec 31, 2024 -10.22%
Jun 30, 2024 -5.20%
Dec 31, 2023 -3.31%
Sep 30, 2023 -97.52%
Jun 30, 2023 1.92%
Mar 31, 2023 -7.96%
Dec 31, 2022 3.96%
Sep 30, 2022 27.17%
Jun 30, 2022 8.74%
Mar 31, 2022 4,030.05%
Dec 31, 2021 -3.82%
Sep 30, 2021 96.83%
Jun 30, 2021 -9.96%
Mar 31, 2021 10,252.93%
Dec 31, 2020 -7.70%
Sep 30, 2020 2,049.51%
Jun 30, 2020 203.48%
Mar 31, 2020 -50.88%